2006
DOI: 10.1016/j.ijrobp.2006.06.047
|View full text |Cite
|
Sign up to set email alerts
|

Potential advantage of studying the lymphatic drainage by sentinel node technique and SPECT-CT image fusion for pelvic irradiation of prostate cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
24
1
3

Year Published

2008
2008
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(30 citation statements)
references
References 20 publications
2
24
1
3
Order By: Relevance
“…In 11 patients, fusion images correlated reasonably well with intraoperative findings: 87% of the lymph node locations visualized on SPECT/CT fusion images were confirmed by the surgeons (20). Furthermore, Krengli et al described how preoperative imaging of lymph drainage with SPECT/CT in prostate cancer patients can alter the radiotherapy regime and lead to optimization of pelvic irradiation (21).…”
Section: Discussionmentioning
confidence: 99%
“…In 11 patients, fusion images correlated reasonably well with intraoperative findings: 87% of the lymph node locations visualized on SPECT/CT fusion images were confirmed by the surgeons (20). Furthermore, Krengli et al described how preoperative imaging of lymph drainage with SPECT/CT in prostate cancer patients can alter the radiotherapy regime and lead to optimization of pelvic irradiation (21).…”
Section: Discussionmentioning
confidence: 99%
“…Figure 4 shows an example of a presacral sentinel node that is only visualized on SPECT/CT images. Preoperative imaging of lymph drainage with SPECT/CT can also alter the targeted radiotherapy field and optimize pelvic irradiation [48].…”
Section: Spect/ct In Patients With Other Malignanciesmentioning
confidence: 99%
“…pimonidazole, EF5) (16)(17)(18). In addition to these invasive techniques, positron emission tomography (PET) (19,20) and single-photon emission computed tomography (SPECT) with CT image fusion (21) hold promise for identifying tumor hypoxia non-invasively at both the global and local level. Many hypoxia-targeting molecules labeled with positron-emitting radionuclides have been developed (19,20,(22)(23)(24)(25)(26).…”
Section: Introductionmentioning
confidence: 99%